Progressive resistance training in head and neck cancer patients during concomitant chemoradiotherapy -- design of the DAHANCA 31 randomized trial

Overview of attention for article published in BMC Cancer, June 2017

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

So far, Altmetric has seen 7 X posts from 7 X users, with an upper bound of 31,709 followers.

RT @cd_fuller: @SprakerMDPhD Yes; DAHANCA 25b from @profOvergaard suggests benefit for head and neck survivors: https://t.co/eKeV175hLo; no…

RT @cd_fuller: @SprakerMDPhD Yes; DAHANCA 25b from @profOvergaard suggests benefit for head and neck survivors: https://t.co/eKeV175hLo; no…

@SprakerMDPhD Yes; DAHANCA 25b from @profOvergaard suggests benefit for head and neck survivors: https://t.co/eKeV175hLo; now waiting on DAHANCA 31 (https://t.co/k5TvKLsSdV)

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.